Skip to content

Methylcobalamin vs Cyanocobalamin: What the Studies Show for Absorption, Nerve Pain and Your Kidneys

Methylcobalamin and cyanocobalamin are two forms of vitamin B12, and no human trial cited here shows one is absorbed better or works better; NIH's Office of Dietary Supplements says there is no evidence that absorption varies by form (grade D for any difference). Methylcobalamin eased diabetic nerve damage against placebo in one 90-person trial (grade C). With diabetic kidney disease, high-dose B vitamins including B12 sped kidney decline in a 238-person trial.

Cyanocobalamin is the most common form of vitamin B12 in supplements; methylcobalamin is one of the two forms your cells actually use. NIH's Office of Dietary Supplements (ODS) says methylcobalamin and 5-deoxyadenosylcobalamin are "the metabolically active forms", while hydroxycobalamin and cyanocobalamin "become biologically active after they are converted" (NIH ODS). Cyanocobalamin carries a cyanide group that the body splits off (Paul 2017).

The short version

  • No human trial cited here compared the two forms for absorption or for any health outcome. ODS says: "No evidence indicates that absorption rates of vitamin B12 in supplements vary by form of the vitamin" (NIH ODS). The only direct comparison the reviews describe in detail was in animals; a 1965 report of 3 human retention studies is cited without results we could check. Grade D (Paul 2017).
  • Reviews disagree on whether it matters. One concludes the active forms are unlikely to beat cyanocobalamin (Obeid 2015); another prefers them, and one of its two authors is a supplement company's chief medical officer (Paul 2017).
  • Nerve damage from diabetes: methylcobalamin improved nerve tests and pain against placebo in one year-long trial of 90 people taking metformin. Grade C (Didangelos 2021). Cyanocobalamin was not tested against it.
  • Kidney disease: in 238 people with kidney disease from diabetes, a high-dose tablet of folic acid, B6 and B12 made kidney filtration fall faster than placebo. Grade C for harm in that group (House 2010). That trial's senior author blames the cyanocobalamin form, an idea no trial has tested (Spence 2016).
Question (who, compared with what)What the studies foundSizeGrade
Methylcobalamin vs cyanocobalamin, absorption or retentionOne animal study; 3 human retention studies from 1965 cited without checkable resultsNot applicableD
Methylcobalamin for diabetic nerve damage (90 adults on metformin, vs placebo)Nerve tests and pain improvedOne trialC
Oral B12 vs injections for deficiency (adults with deficiency)Blood levels rose about as much3 trials, 153 peopleC
High-dose B vitamins incl. cyanocobalamin in diabetic kidney disease (238, vs placebo)Faster fall in kidney filtrationOne trialC, harm

What is the difference between methylcobalamin and cyanocobalamin?

All forms of B12 share a cobalt-containing core. Inside cells, the methyl or cyanide group comes off, and the core is rebuilt into the two working forms, methylcobalamin and adenosylcobalamin, whichever form you swallowed (Obeid 2015; Paul 2017). Cyanocobalamin is made in factories and used in fortified foods and many supplements; methylcobalamin, adenosylcobalamin and hydroxocobalamin occur in foods and the body (Paul 2017). The reviews cited here do not say how much cyanide a tablet releases.

Hydroxocobalamin and cyanocobalamin are also prescription injections, mostly for people who cannot absorb B12, such as those with pernicious anemia (NIH ODS). Adenosylcobalamin is sold in some supplements too.

Is methylcobalamin better absorbed than cyanocobalamin?

Grade D: not shown in people. The 2017 review that favours the active forms describes one animal study: the two forms reached the blood equally, but about 3 times more cyanocobalamin was lost in urine and 13% more B12 was stored in the liver after methylcobalamin. It also cites a 1965 report reviewing 3 human studies in which cyanocobalamin was retained less than other forms and more was lost in urine (Paul 2017). That report's PubMed record carries no results to check.

The other review, by B12 chemists, argues that every form follows the same route inside cells, so supplementing methylcobalamin "is unlikely to be advantageous compared to" cyanocobalamin (Obeid 2015). ODS adds that absorption is about 50% at very small doses and much lower at large ones, whatever the form (NIH ODS).

Which form corrects a deficiency better?

Grade C: both forms work; no trial cited here pitted one against the other. The 2017 review notes that all forms "have been shown in clinical studies to improve vitamin B12 status" (Paul 2017). After weight-loss (gastric bypass) surgery, ODS reports that high-dose methylcobalamin tablets appear as effective as hydroxocobalamin injections at bringing B12 back to normal (NIH ODS).

Route matters more than form in the trials. A Cochrane review of 3 trials (153 adults with deficiency, followed 3 to 4 months) found tablets raised blood B12 about as far as injections, on low-quality evidence; in one trial 2 of 30 people (6.7%) taking tablets left early because of adverse events, and the reviewers judged tablets as safe as injections only on very low-quality evidence (Wang 2018). A 2024 analysis of 13 studies (4,275 people) found no significant difference between tablets, under-the-tongue forms and injections (Abdelwahab 2024). Our B12 energy guide covers tablets against shots in more detail.

Is methylcobalamin better for nerve pain or neuropathy?

Grade C for methylcobalamin alone; no trial cited here compared it with cyanocobalamin. In a double-blind trial, 90 people with type 2 diabetes who had taken metformin for at least 4 years, had nerve damage and had B12 below 400 pmol/L took methylcobalamin tablets or placebo for a year. Compared with placebo, nerve conduction, vibration sense, pain and quality of life improved; heart-rhythm nerve tests did not. A drug company supplied the tablets (Didangelos 2021).

Pooled evidence is weaker. A 2020 review of 15 trials (1,707 people with diabetic or shingles-related nerve damage), most at high risk of bias, compared methylcobalamin with other treatments rather than placebo; it found more "clinical efficacy" but no change in pain or symptom scores for methylcobalamin alone (Sawangjit 2020). A 2022 analysis of 6 diabetic neuropathy trials found less pain and fewer symptoms with B12, but 4 of the 6 combined B12 with other vitamins or nutrients (Karedath 2022).

Who needs vitamin B12?

ODS lists these groups as more likely to run low (NIH ODS):

  • Older adults: depending on the definition, 3% to 43% of older adults living at home are deficient, especially those with atrophic gastritis, a thinning of the stomach lining.
  • Pernicious anemia: an autoimmune disease that stops the stomach making intrinsic factor, the protein that carries B12 into the body. Without treatment it causes deficiency even with a good diet.
  • Vegans and vegetarians: across 17 studies, adult vegans had lower blood B12 and higher homocysteine (a marker of B12 shortage) than meat-eaters, and vegans who used B12 supplements had better results on every marker (Niklewicz 2024).
  • Metformin: across 31 studies of people with diabetes, metformin users were about twice as likely to be B12 deficient (risk ratio 2.09) (Yang 2019). See does metformin lower vitamin B12?
  • Acid-reducing pills (PPIs): across 25 studies, deficiency was slightly more common in users (odds ratio 1.42), and the authors called the link unclear (Choudhury 2023).
  • Gut surgery or bowel disease that cuts absorption, such as weight-loss surgery or coeliac disease.

Don't stop metformin or an acid reducer on your own; ask your prescriber whether your B12 should be checked. Our B12 deficiency protocol and condition page list the graded findings.

Is cyanocobalamin bad for your kidneys?

Grade C for harm from high-dose B vitamins in diabetic kidney disease; the role of the cyanocobalamin form is unproved. In the DIVINe trial, 238 people with diabetic kidney disease took a daily tablet of folic acid, B6 and B12 or placebo for up to 3 years. Kidney filtration fell by 16.5 units on the vitamins against 10.7 on placebo, and a combined outcome of heart attack, stroke, artery procedures or death was more common (hazard ratio 2.0) (House 2010).

The trial's senior author later wrote that "B vitamins including cyanocobalamin were harmful" in DIVINe and suggested cyanide build-up when kidneys fail (Spence 2016), and that methylcobalamin should be used instead in kidney impairment (Spence 2013). Those are expert opinions, not trial results: DIVINe tested a mix of three vitamins against placebo, not one B12 form against another. If you have kidney disease, the B-vitamin note in the safety section below applies whatever the form.

So which should you choose?

On the evidence cited here, either form can correct low B12, and no human trial shows one beats the other. Methylcobalamin has one nerve-damage trial against placebo. Cyanocobalamin is the common, cheaper form, and it was part of the high-dose mix in the kidney-disease trial above (Spence 2016).

What we'd skip

  • Paying more for methylcobalamin to absorb more B12: ODS says no evidence shows absorption varies by form (NIH ODS), and the only direct comparison described in detail was in animals (Paul 2017).
  • Choosing a B12 form based on a home genetic test: the review that proposes it says the relevant gene variants "are not currently reported in commercial tests" (Paul 2017).
  • High-dose B-vitamin combinations with diabetic kidney disease, unless your kidney team advises them (House 2010).

Safety and interactions

  • Vitamin B12 has not been shown to cause any harm, even at high doses. The FNB did not establish a UL for vitamin B12 because of its low potential for toxicity. Vitamin B12 supplements can interact or interfere with some medicines that you take. Metformin might reduce vitamin B12 absorption and lower blood levels of vitamin B12. Tell your doctor, pharmacist, and other health care providers about any dietary supplements and prescription or over-the-counter medicines you take. (NIH ODS)
  • High-dose B vitamins are not harmless: in a trial of 238 people with diabetic nephropathy, a daily tablet of 2.5 mg folic acid, 25 mg vitamin B6 and 1 mg vitamin B12 made kidney filtration (GFR) fall faster than placebo, and a combined outcome of heart attack, stroke, procedures to reopen arteries or death was more common (hazard ratio 2.0, 95% range 1.0 to 4.0). In an observational study of 77,118 adults aged 50 to 76, men whose separate supplements over the previous 10 years averaged more than 20 mg a day of vitamin B6 or more than 55 mcg a day of vitamin B12 had more lung cancer (hazard ratios 1.82 and 1.98), higher still in smokers; women showed no link, and a study of this kind cannot prove cause. (House 2010; Brasky 2017)
  • Folic acid in B-complex products: NIH's Office of Dietary Supplements (ODS) says: 'Folate that is naturally present in food and beverages is not harmful. However, you should not consume folate in supplements or fortified foods and beverages in amounts above the upper limit, unless recommended by a health care provider. Taking large amounts of folate supplements might hide a vitamin B12 deficiency because these supplements can correct the anemia that the vitamin B12 deficiency causes but not the nerve damage that the vitamin B12 deficiency also causes. The vitamin B12 deficiency can lead to permanent damage of the brain, spinal cord, and nerves. Large doses of folate supplements might also worsen the symptoms of vitamin B12 deficiency. High doses of folic acid might increase the risk of colorectal cancer and possibly other cancers in some people. High doses can also lead to more folic acid in the body than it can use, but whether these increased folic acid levels are harmful is not completely clear.' On medicines it says: 'Folate supplements can interact with several medications. Here are some examples: Folate supplements could interfere with methotrexate (Rheumatrex, Trexall) when taken to treat cancer. Taking antiepileptic or antiseizure medications, such as phenytoin (Dilantin), carbamazepine (Carbatrol, Tegretol, Equetro, Epitol) and valproate (Depacon), could reduce blood levels of folate. Also, taking folate supplements could reduce blood levels of these medications. Taking sulfasalazine (Azulfidine) for ulcerative colitis could reduce the body’s ability to absorb folate and cause folate deficiency. Tell your doctor, pharmacist, and other health care providers about any dietary supplements and medicines you take.' (NIH ODS)
  • Pregnancy: check any supplement with your midwife or obstetric team first.
  • Breastfeeding? Ask your midwife, doctor or a lactation specialist, who can check what passes into breast milk (LactMed).

When to see a doctor

  • Soon for numbness or tingling in the hands or feet, unsteady walking, memory trouble, a sore red tongue, or tiredness with pale skin: ODS lists these among the signs of B12 deficiency (NIH ODS), and other nerve and blood diseases cause them too, so get a blood test before you treat it yourself.
  • If you have pernicious anemia, have had stomach or bowel surgery, or have been told you can't absorb B12, your doctor decides between tablets and injections; injections are prescription medicine (NIH ODS).
  • If you have kidney disease, ask your kidney team before taking any high-dose B vitamin.
  • If you take metformin or an acid reducer, don't stop it on your own; ask the prescriber or pharmacist about a B12 test.

FAQ

Is methylcobalamin better than cyanocobalamin? Not on the evidence cited here. No human trial compared them for absorption or health outcomes, NIH's Office of Dietary Supplements says no evidence shows absorption varies by form, and the only direct comparison described in detail was in animals (grade D).

Is cyanocobalamin bad for you? For most people it has not been shown to cause harm. In a trial of 238 people whose diabetes had damaged their kidneys, daily high-dose folic acid, B6 and B12 (cyanocobalamin, according to the trial's senior author) sped up kidney decline against placebo (grade C for harm in that group); whether the cyanocobalamin form caused it is untested.

What is the best form of B12? No form has been shown best. Tablets of either form raise blood B12, and in adults with deficiency, tablets raised levels about as far as injections (grade C, low-quality evidence).

Does methylcobalamin help neuropathy? In one year-long trial of 90 people with diabetes on metformin, methylcobalamin improved nerve tests and pain against placebo (grade C). It has not been tested against cyanocobalamin.

Sources

  1. Paul C, et al. Comparative Bioavailability and Utilization of Particular Forms of B(12) Supplements With Potential to Mitigate B(12)-related Genetic Polymorphisms. Integr Med (Encinitas). 2017. PubMed 28223907
  2. Obeid R, et al. Cobalamin coenzyme forms are not likely to be superior to cyano- and hydroxyl-cobalamin in prevention or treatment of cobalamin deficiency. Mol Nutr Food Res. 2015. PubMed 25820384 · doi:10.1002/mnfr.201500019
  3. Didangelos T, et al. Vitamin B12 Supplementation in Diabetic Neuropathy: A 1-Year, Randomized, Double-Blind, Placebo-Controlled Trial. Nutrients. 2021. PubMed 33513879 · doi:10.3390/nu13020395
  4. House AA, et al. Effect of B-vitamin therapy on progression of diabetic nephropathy: a randomized controlled trial. JAMA. 2010. PubMed 20424250 · doi:10.1001/jama.2010.490
  5. Spence JD. Homocysteine lowering for stroke prevention: Unravelling the complexity of the evidence. Int J Stroke. 2016. PubMed 27462097 · doi:10.1177/1747493016662038
  6. Wang H, et al. Oral vitamin B(12) versus intramuscular vitamin B(12) for vitamin B(12) deficiency. Cochrane Database Syst Rev. 2018. PubMed 29543316 · doi:10.1002/14651858.CD004655.pub3
  7. Abdelwahab OA, et al. Efficacy of different routes of vitamin B12 supplementation for the treatment of patients with vitamin B12 deficiency: A systematic review and network meta-analysis. Ir J Med Sci. 2024. PubMed 38231320 · doi:10.1007/s11845-023-03602-4
  8. Sawangjit R, et al. Efficacy and Safety of Mecobalamin on Peripheral Neuropathy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. J Altern Complement Med. 2020. PubMed 32716261 · doi:10.1089/acm.2020.0068
  9. Karedath J, et al. The Impact of Vitamin B12 Supplementation on Clinical Outcomes in Patients With Diabetic Neuropathy: A Meta-Analysis of Randomized Controlled Trials. Cureus. 2022. PubMed 36457818 · doi:10.7759/cureus.31783
  10. Niklewicz A, et al. A systematic review and meta-analysis of functional vitamin B12 status among adult vegans. Nutr Bull. 2024. PubMed 39373282 · doi:10.1111/nbu.12712
  11. Yang W, et al. Associations between metformin use and vitamin B(12) levels, anemia, and neuropathy in patients with diabetes: a meta-analysis. J Diabetes. 2019. PubMed 30615306 · doi:10.1111/1753-0407.12900
  12. Choudhury A, et al. Vitamin B12 deficiency and use of proton pump inhibitors: a systematic review and meta-analysis. Expert Rev Gastroenterol Hepatol. 2023. PubMed 37060552 · doi:10.1080/17474124.2023.2204229
  13. Spence JD. B vitamin therapy for homocysteine: renal function and vitamin B12 determine cardiovascular outcomes. Clin Chem Lab Med. 2013. PubMed 23449527 · doi:10.1515/cclm-2012-0465
  14. Brasky TM, et al. Long-Term, Supplemental, One-Carbon Metabolism-Related Vitamin B Use in Relation to Lung Cancer Risk in the Vitamins and Lifestyle (VITAL) Cohort. J Clin Oncol. 2017. PubMed 28829668 · doi:10.1200/JCO.2017.72.7735
  15. National Institute of Child Health and Human Development. Vitamin B(12). Drugs and Lactation Database (LactMed). 2006. PubMed 30489717